Pacira | PCRX - Capital Ordinário





Capital Ordinário Alterar Data
Astellas Pharma JPY 1.79B 81K 2026-03
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Cara Therapeutics USD 9.38M 9.38M 2025-09
Coherus Biosciences USD 121.16M 4.92M 2025-12
Heron Therapeutics USD 188.31M 4.99M 2025-12
Ironwood Pharmaceuticals USD 160K 0 2024-12
J&J USD 2.41B 1.74M 2025-12
Ligand Pharmaceuticals USD 19.66M 19.64M 2025-09
Nektar Therapeutics USD 20.38M 20.36M 2025-12
Novo Nordisk DKK 4.44B 0 2025-12
Omeros USD 611K 17K 2023-12
Pacira USD 39.31M 1.81M 2026-03
Perrigo USD 138.1M 500K 2026-03
Pfizer USD 5.7B 13M 2026-03
Supernus Pharmaceuticals USD 58.04M 582K 2026-03
Teva Pharmaceutical Industries USD 1.16B 16.72M 2026-03
Xeris Pharmaceuticals USD 166.22M 687.16K 2025-12
Xoma USD 87K 1000 2024-06
Zoetis USD 420.35M 4.58M 2026-03